Fred Hassan Joins Bausch & Lomb Board of Directors

ROCHESTER, N.Y., Nov. 12 /PRNewswire/ -- Bausch & Lomb, the global eye health
company, today announced that Fred Hassan has been elected to its Board of
Directors.

Mr. Hassan was chairman and CEO of Schering-Plough Corporation from 2003 until
its acquisition by Merck & Co., Inc. on November 3. Before joining
Schering-Plough, he served as CEO (from 2000 to 2001) and as chairman and CEO
(from 2001 to 2003) of Pharmacia Corporation until the company was acquired by
Pfizer Inc. in 2003. From 1997 to 2000, Mr. Hassan was CEO of Pharmacia &
Upjohn, Inc., which merged with Monsanto Company in 2000 to become Pharmacia
Corporation. From 1972 to 1997, he served in various senior management roles
at major pharmaceutical companies.

"Bausch & Lomb and its customers will benefit from Fred Hassan's extensive
global business experience and his in-depth knowledge of the healthcare
industry," said Gerald M. Ostrov, chairman and chief executive officer, Bausch
& Lomb. "We will especially value Fred's insights as we develop and market
innovative pharmaceutical products for the global eye health industry."

Mr. Hassan is the past chairman of the Board of Directors of the
Pharmaceutical Research and Manufacturers of America (PhRMA) and is the past
chairman of the HealthCare Institute of New Jersey. He is also the immediate
past president of the International Federation of Pharmaceutical Manufacturers
Associations. In addition, he is a member of the Board of Directors of Time
Warner Inc. and the Lead Director on the Board of Directors of Avon Products,
Inc. He holds a bachelor's of science degree from the Imperial College of
Science and Technology at the University of London and an M.B.A. degree from
Harvard Business School.

Mr. Hassan joins board members Joseph P. Landy, Elizabeth H. Weatherman and
Sean D. Carney, all managing directors of Warburg Pincus LLC; D. Scott
Mackesy, general partner, Welsh Carson Anderson & Stowe; Richard Wallman,
retired CFO, Honeywell International, Inc.; R. Kerry Clark, retired CEO,
Cardinal Health; Bob Palmisano, president, CEO and director, ev3 Inc.; and
Gerald M. Ostrov.

About Bausch & Lomb

Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core
businesses include contact lenses and lens care products, ophthalmic surgical
devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb
name is one of the best-known and most respected healthcare brands in the
world. Founded in 1853, the company is headquartered in Rochester, N.Y., and
employs more than 10,000 people worldwide. Its products are available in more
than 100 countries. More information is available at www.bausch.com.

SOURCE Bausch & Lomb

Elizabeth Murphy, Manager, Corporate Communications and Public Affairs, Bausch
& Lomb, +1-585-338-8528, Elizabeth.Murphy@bausch.com